Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tensile Strength/drug effects"'
Publikováno v:
Tissue Engineering. Part C. Methods, 20(5), 431-9. Mary Ann Liebert Inc.
Silk fibroin has previously been described as a promising candidate for ligament tissue engineering (TE) approaches. For biocompatibility reasons, silkworm silk requires removal of sericin, which can elicit adverse immune responses in the human body.
Publikováno v:
Jensen, J S, Petersen, N B, Biagini, M, Bollen, P & Qvist, N 2015, ' Infliximab treatment reduces tensile strength in intestinal anastomosis ', Journal of Surgical Research, vol. 193, no. 1, pp. 145-152 . https://doi.org/10.1016/j.jss.2014.07.022
Background: The antitumor necrosis factor (infliximab [IFX]) has gained widespread use in the treatment of inflammatory bowel disease. However, several patients must undergo surgical treatment due to treatment failure and there is a potential risk th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a7449ce6a96e51a05b38743876fd83
https://portal.findresearcher.sdu.dk/da/publications/a5634491-036e-462c-a36c-c51079b839a2
https://portal.findresearcher.sdu.dk/da/publications/a5634491-036e-462c-a36c-c51079b839a2
Autor:
Jean-Christophe Tille, Benjamin Nottelet, D. Mandracchia, Robert Gurny, Erman Pektok, Beat H. Walpoth, Michael Möller
Publikováno v:
Journal of Biomedical Materials Research Part A
Journal of Biomedical Materials Research Part A, Wiley, 2009, 89 (4), pp.865-75. ⟨10.1002/jbm.a.32023⟩
Journal of Biomedical Materials Research. A, Vol. 89, No 4 (2009) pp. 865-875
Journal of Biomedical Materials Research Part A, Wiley, 2009, 89 (4), pp.865-75. ⟨10.1002/jbm.a.32023⟩
Journal of Biomedical Materials Research. A, Vol. 89, No 4 (2009) pp. 865-875
International audience; Because of the severe increase of mortality by cardiovascular diseases, there has been rising interest among the tissue-engineering community for small-sized blood vessel substitutes. Here we present small diameter vascular gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646a560444bbdc2b92f9b66003b39abc
https://hal.archives-ouvertes.fr/hal-00416778
https://hal.archives-ouvertes.fr/hal-00416778
Autor:
Richard J. Wong, Duncan A. McGrouther, Jim Bush, Arnaud Garcon, Nick Goldspink, Mark W. J. Ferguson, Chris Platt, Anthony D. Metcalfe, Jason Wong
Publikováno v:
Wong, J K F, Metcalfe, A D, Wong, R, Bush, J, Platt, C, Garcon, A, Goldspink, N, McGrouther, D A & Ferguson, M W J 2014, ' Reduction of tendon adhesions following administration of Adaprev, a hypertonic solution of mannose-6-phosphate : Mechanism of action studies ', PLoS ONE, vol. 9, no. 11, e112672 . https://doi.org/10.1371/journal.pone.0112672
PLoS ONE, Vol 9, Iss 11, p e112672 (2014)
Wong, J K F, Metcalfe, A D, Wong, R, Bush, J, Platt, C, Garcon, A, Goldspink, N, McGrouther, D A & Ferguson, M W J 2014, ' Reduction of tendon adhesions following administration of Adaprev, a hypertonic solution of mannose-6-phosphate : Mechanism of action studies ', P L o S One, vol. 9, no. 11, e112672 . https://doi.org/10.1371/journal.pone.0112672
PLoS ONE
PLoS ONE, Vol 9, Iss 11, p e112672 (2014)
Wong, J K F, Metcalfe, A D, Wong, R, Bush, J, Platt, C, Garcon, A, Goldspink, N, McGrouther, D A & Ferguson, M W J 2014, ' Reduction of tendon adhesions following administration of Adaprev, a hypertonic solution of mannose-6-phosphate : Mechanism of action studies ', P L o S One, vol. 9, no. 11, e112672 . https://doi.org/10.1371/journal.pone.0112672
PLoS ONE
Repaired tendons may be complicated by progressive fibrosis, causing adhesion formation or tendon softening leading to tendon rupture and subsequent reduced range of motion. There are few therapies available which improve the gliding of damaged tendo
Publikováno v:
Frostberg, E, Ström, P, Gerke, O & Qvist, N 2014, ' Infliximab's influence on anastomotic strength and degree of inflammation in intestinal surgery in a rabbit model ', B M C Surgery, vol. 14, no. 1, 23, pp. 23 . https://doi.org/10.1186/1471-2482-14-23
BMC Surgery
BMC Surgery
BACKGROUND: Infliximab, a TNF-alpha inhibitor, is a potent anti-inflammatory drug in the treatment of inflammatory bowel diseases. Recent studies have investigated the effect of infliximab treatment on postoperative complications such as anastomotic